ADLER A, CIESLEWICZ G, IRVIN CG. Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. Am J Physiol 2004;97(1):286-292.
AGRAWAL DK, EDWAN J, KANDIMALLA ER, YU D, BHAGAT L, WANG D, et al. Novel immunomodulatory oligonucleotides prevent development of allergic airway inflammation and airway hyperresponsiveness in asthma. Int Immunopharmacol 2004;4(1):127-138.
AKIYAMA H, TESHIMA R, SAKUSHIMA JI, OKUNUKI H, GODA Y, SAWADA JI, et al.
Examination of oral sensitization with ovalbumin in Brown Norway rats and three strains of mice. Immunol Lett 2001;78(1):1-5.
ALBERTINE KH, WANG L, WATANABE S, MARATHE GK, ZIMMERMANN GA, MCINTYRE
TM. Temporal correlation of measurements of airway hyperresponsiveness in ovalbumin-sensitized mice. Am J Physiol Lung Cell Mol Physiol 2002;283(1):L219-L233.
ANSFIELD MJ,KALTREIDER HB,BENSON BJ,CALDWELL JL.Immunosuppressive activity of canine pulmonary surface active material. J Immunol 1979 Mar;122(3):1062-1066.
ANSFIELD MJ, BENSON BJ, KALTREIDER HB. Immunosuppression by surface-active material: lack of species specificity. Am Rev Respir Dis 1979 Oct;120(4):949-952.
ANZUETO A, JUBRAN A,OHAR JA,PIQUETTE CA,RENNARD SI,COLICE G,et al.Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial. JAMA 1997;278(17):1426-1431.
AVERY ME, MEAD J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959;97(5 Pt 1):517-523.
BABU KS,WOODCOCK DA,SMITH SE,STANIFORTH JN,HOLGATE ST,CONWAY JH.Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma. Eur Respir J 2003;21(6):1046-1049.
BANERJEE R,PUNIYANI RR.Exogenous surfactant therapy and mucus rheology in chronic obstructive airway disease. J Biomater Appl 2000;14(3):243-272.
BARITUSSIO A. Lung surfactant, asthma, and allergens: a story in evolution. Am J Respir Crit Care Med 2004;169(5):550-551.
BATES J, IRVIN C, BRUSASCO V, DRAZEN J, FREDBERG J, LORING S, et al. The Use and Misuse of Penh in Animal Models of Lung Disease [correspondence]. Am J Respir Cell Mol Biol 2004;31(3):373-374.
BAUDOUIN SV.Exogenous surfactant replacement in ARDS – one day, someday or never?
N Engl J Med 2004;351(9):853-855.
BIOZZI G,MOUTON D,SANT'ANNA OA,PASSOS HC,GENNARI M,REIS MH,et al.Genetics of immunoresponsiveness to natural antigens in the mouse. Curr Top Microbiol Immunol 1979;85:31-98.
BLEASE K, JAKUBZICK C,WESTWICK J,LUKACS N, KUNKEL SL,HOGABOAM.Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma.
Immunology 2001;166(8):5219-5224.
BORRON P,VELDHUIZEN RAW,LEWIS JF,POSSMAYER F, CAVENEY A, INCHLEY K, et al.
Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production. Am J Respir Cell Mol Biol 1996;15(1):115-121.
BORRON PJ,CROUCH EC,LEWIS JF,WRIGHT JR,POSSMAYER F,FRAHER LJ.Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J Immunol 1998;161(9):4599-4603.
BROWN RH, WALTERS DM, GREENBERG RS, MITZNER W. A method of endotracheal intubation and pulmonary functional assessment for repeated studies in mice. J Appl Physiol 1999;87(6):2362-5.
BURROWS B, SEARS MR, FLANNERY EM, HERBISON GP, HOLDAWAY MD, SILVA PA.
Relation of the course of bronchial responsiveness from age 9 to age 15 to allergy. Am J Respir Crit Care Med 1995;152(4 Pt 1):1302-1308.
CATANZARO A, RICHMAN P,BATCHER S,HALLMAN M.Immunomodulation by pulmonary surfactant. J Lab Clin Med 1988;112(6):727-734.
CHENG G,UEDA T,NAKAJIMA H,NAKAJIMA A,KINJYO S,MOTOJIMA S, et al.Suppressive
effects of SP-A on ionomycin-induced IL-8 production and release by eosinophils. Int Arch Allergy Immunol 1998;117 Suppl 1:59-62.
CHENG G, UEDA T, NAKAJIMA H, NAKAJIMA A, ARIMA M, KINJYO S, et al. Surfactant protein A exhibits inhibitory effect on eosinophils IL-8 production. Biochem Biophys Res Commun 2000 Apr;270(3):831-835.
CHENG G, UEDA T, NUMAO T, KUROKI Y, NAKAJIMA H, FUKUSHIMA Y, et al. Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma. Eur Respir J 2000 Sep;16(5):831-835.
CIESLEWICZ G,TOMKINSON A,ADLER A,DUEZ C,SCHWARZE J,TAKEDA K, et al.The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J Clin Invest 1999;104(3):301-308.
CLARK H, REID K. The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema. Arch Dis Child 2003;88(11):981-984.
CORRY DB, FOLKESSON HG, WARNOCK ML, ERLE DJ, MATTHAY MA, WIENER -KRONISH JP, et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996;183(1):109-117.
CORRY DB, GRUNIG G, HADEIBA H, KURUP VP, WARNOCK ML, SHEPPARD D, et al.
Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 1998;4(5):344-355.
CROSBY JR,CIESLEWICZ G,BORCHERS M,HINES E,CARRIGAN P,LEE JJ,et al.Early phase bronchoconstriction in the mouse requires allergen-specific IgG. J Immunol 2002;168(8):4050-4054.
CROUCH E, WRIGHT JR. Surfactant protein A and D and pulmonary host defence. Annu Rev Physiol 2001;63:521-554.
DELORME MP,MOSS OR.Pulmonary function assessment by whole-body plethysmography in restrained versus unrestrained mice. J Pharmacol Toxicol Methods 2002;47(1):1-10.
DOBBS LG, MASON RJ. Stimulation of secretion of disaturated phosphatidylcholine from isolated alveolar type II cells by 12-O-tetradecanoyl-13-phorbol acetate. Am Rev Respir Dis 1978;118(4):705-733.
DOHI M, TSUKAMOTO S, NAGAHORI T, SHINAGAWA K, SAITOH K, TANAKA Y, et al.
Noninvasive system for evaluating the allergen-specific airway response in a murine model of asthma. Lab Invest 1999;79(12):1559-1571.
DRAZEN JM, FINN PW, DE SANCTIS GT. Mouse modells of airway responsiveness:
physiological basis of observed outcomes and analysis of selected examples using these outcome indicators. Annu Rev Physiol 1999;61:593-625.
EKELUND L,BURGOYNE R,BRYMER D,ENHORNING G.Pulmonary surfactant release in fetal rabbits as affected by terbutaline and aminophyllin. Scand J Clin Lab Invest 1981;41(3):237-245.
ENHORNING G, HOLM BA. Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube. J Appl Physiol 1993;74(6):2922-2927.
ENHORNING G, DUFFY LC, WELLIVER RC. Pulmonary surfactant maintains patency of conducting airways in the rat. Am J Respir Crit Care Med 1995;151(2 Pt 1):554-556.
ENHORNING G,HOHLFELD J,KRUG N,LEMA G,WELLIVER RC.Surfactant function affected by airway inflammation and cooling: possible impact on exercise-induced asthma. Eur Respir J 2000;15(3):532-538.
EPSTEIN MM. Do mouse models of allergic asthma mimic clinical disease? Int Arch Allergy Immunol 2004;133(1):84-100.
ERPENBECK VJ, HAGENBERG A, DULKYS Y, ELSNER J, BAELDER R, KRENTEL H, et al.
Natural porcine surfactant augments airway inflammation after allergen challenge in patients with asthma. Am J Respir Crit Care Med 2004;169(5):578-586.
ERPENBECK VJ,MALHERBE DC,SOMMER S,SCHMIEDL A,STEINHILBER W,GHIO AJ,et al.
Surfactant protein D increases phagocytosis and aggregation of pollen-allergen starch granules. Am J Physiol Lung Cell Mol Physiol 2005;288(4):L692-L698.
EUM SY,HAILÉ S,LEFORT J,HUERRE M,VARGAFTIG BB.Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc Natl Acad Sci U S A 1995;92(26):12290-12294.
EWALDSSON B, FOGELMARK B, FEINSTEIN R,EWALDSSON L,RYLANDER R.Microbial cell wall product contamination of bedding may induce pulmonary inflammation in rats.
Lab Anim 2002;36(3):282-290.
FINOTTO S,NEURATH MF,GLICKMAN JN,QUIN S,LEHR HA,GREEN FH,et al.Development
of spontaneous airway changes consistent with human asthma in mice lacking T-bet.
Science 2002;295(5553):336-338.
FLANDRE TD, LEROY PL, DESMECHT, DJ. Effect of somatic growth, strain, and sex on double-chamber plethysmographic respiratory function values in healthy mice. J Appl Physiol 2003;94(3):1129-1136.
FOLDES-FILEP EP, SIROIS P, FILEP JG. Pulmonary surfactant lipids inhibit prostanoid production of guinea pig alveolar macrophages. J Leukoc Biol 1994;56(4):475-480.
FOSTER PS, HOGAN SP, RAMSAY AJ, MATTHAEI KI, YOUNG IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183(1):195-201.
FUCHIMUKAI T,FUJIWARA T,TAKAHASHI A,ENHORNING G.Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 1987;62(2):429-437.
GAJEWSKA BU, SWIRSKI FK, ALVAREZ D, RITZ SA,GONCHAROVA S,CUNDALL M, et al.
Temporal-spatial analysis of the immune response in a murine model of ovalbumin-induced airways inflammation. Am J Respir Cell Mol Biol 2001;25(3):326-334.
GEHR P,IM HOF V,GEISER M,SCHÜRCH S.Der mukoziliäre Apparat der Lunge – Die Rolle des Surfactant. Schweiz Med Wochenschr 2000;130(19):691-698.
GELFAND EW. Pro: mice are a good model of human airway disease [pro/con editorial].
Am J Respir Crit Care Med 2002;166(1):5-8; discussion 7-8.
GESUNDHEITSBERICHTERSTATTUNG DES BUNDES. Spezialbericht Allergien, Teil 5 Risikofaktoren (1). Spezialbericht Allergien, 2000. Verfügbar unter: URL:
http://www.gbe-bund.de.
GLAAB T, DASER A, BRAUN A, NEUHAUS-STEINMETZ U, FABEL H,ALARIE Y, et al.Tidal midexpiratory flow as a measure of airway hyperresponsiveness in allergic mice. Am J Physiol Lung Cell Mol Physiol 2001;280(3):L565-L573.
GLAAB T, HOYMANN HG, HOHLFELD JM, KOROLEWITZ R, HECHT M, ALARIE Y, et al.
Noninvasive measurement of midexpiratory flow indicates bronchoconstriction in allergic rats. J Appl Physiol 2002;93(4):1208-1214.
GLAAB T, MITZNER W, BRAUN A, ERNST H, KOROLEWITZ R, HOHLFELD JM, et al.
Repetitive measurement of pulmonary mechanics to inhaled cholinergic challenge in spontaneously breathing mice. J Appl Physiol 2004;97(3):1104-1111.
GLAAB T, ZIEGERT M, BAELDER R, KOROLEWITZ R, BRAUN A, HOHLFELD JM, et al.
Invasive versus noninvasive measurement of allergic and cholinergic airway responsiveness in mice. Respir Res 2005;6(1):139.
GLEICH GJ,KITA H. Bronchial asthma: lessons from murine models. Proc Natl Acad Sci U S A 1997;94(6):2101-2102.
GOLDSMITH CA,NING Y,QIN G,IMRICH A,LAWRENCE J,MURTHY GG,et al. Combined air pollution particle and ozone exposure increases airway responsiveness in mice. Inhal Toxicol 2002;14(4):325-347.
VAN DE GRAAF EA, JANSEN HM, LUTTER R, ALBERTS C, KOBESEN J, DE VRIES J, et al.
Surfactant protein A in bronchoalveolar lavage fluid. J Lab Clin Med 1992;120(2):252-263.
GREEN CJ, KNIGHT J, PRECIOUS S, SIMPKIN S. Metomidate, etomidate and fentanyl as injectable anaesthetic agents in mice. Lab Anim 1981;15(2):171-175.
GRIESE M.Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999;13(6):1455-1476.
GRUNIG G,CORRY DB,LEACH MW,SEYMOUR BW,KURUP VP,RENNICK DM. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 1997;185(6):1089-1099.
HACZKU A, ATOCHINA EN, TOMER Y, CHEN H, SCANLON ST, RUSSO S, et al.
Aspergillus fumigatus-induced allergic airway inflammation alters surfactant homeostasis and lung function in BALB/c mice. Am J Respir Cell Mol Biol 2001;25(1):45-50.
HAILÉ S,LEFORT J, EUM SJ, DUMAREY C, HUERRE M,HEUSSER C, et al.Suppression of immediate and late responses to antigen by a non-anaphylactogenic anti-IgE antibody in a murine model of asthma. Eur Respir J 1999;13(5):961-969.
HAMADA K, GOLDSMITH CA, GOLDMAN A, KOBZIK L.Resistance of very young mice to inhaled allergen sensitization is overcome by coexposure to an air-pollutant aerosol.
Am J Respir Crit Care Med 2000;161(4 Pt 1):1285-1293.
HAMELMANN E, OSHIBA A, PALUH J, BRADLEY K, LOADER J, POTTER TA, et al.
Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a murine model of airway sensitization. J Exp Med 1996;183(4):1719-1729.
HAMELMANN E, SCHWARZE J, TAKEDA K, OSHIBA A, LARSEN GL, IRVIN CG, et al.
Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997;156(3 Pt 1):766-775.
HANSEN G, JIN S, UMETSU DT, CONTI M. Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D. Proc Natl Acad Sci U S A 2000;97(12):6751-6756.
HAYS SR, WOODRUFF PG,KHASHAYAR R, FERRANDO RE, LIU J, FUNG P et al. Allergen challenge causes inflammation but not goblet cell degranulation in asthmatic subjects. J Allergy Clin Immunol 2001;108(5):784-790.
HEELEY EL, HOHLFELD JM, KRUG N, POSTLE AD. Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in asthma. Am J Physiol Lung Cell Mol Physiol 2000;278(2):L305-L311.
VAN HELDEN HP,KUIJPERS WC,DIEMEL RV.Asthmalike symptoms following intratracheal exposure of Guinea pigs to sulfur mustard aerosol: therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal Toxicol 2004;16(8):537-548.
HEROLD G,Herausgeber. Pneumologie. In: Innere Medizin 2004. Köln; 2004. S. 297-307.
HERZ U, BRAUN A, RÜCKERT R, RENZ H. Suppression of neural Various immunological phenotypes are associated with increased airway responsiveness. Clin Exp Allergy 1998;28(5):625-634.
HERZ U,RÜCKERT R,WOLLENHAUPT K,TSCHERNIG T,NEUHAUS-STEINMETZ U,PABST R, et al. Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness – a model for non-allergic asthma. Eur J Immunol 1999;29(3):1021-1031.
HESSEL EM, ZWART A, OOSTVEEN E, VAN OOSTERHOUT AJ, BLYTH DI, NIJKAMP FP.
Repeated measurement of respiratory function and bronchoconstriction in unanesthetized mice. J Appl Physiol 1995;79(5):1711-1716.
HILLS BA.A mechanism for masking receptors with particular application to asthma. Med Hypotheses 1996;46(1):33-41.
HILLS BA,CHEN Y.Suppression of neural activity of bronchial irritant receptors by surface-active phospholipid in comparison with topical drugs commonly prescribed for asthma.
Clin Exp Allergy 2000;30(9):1266-1274.
HOGABOAM CM, GALLINTA CS, TAUB DD, STRIETER RM, KUNKEL SL, LUKACS NW.
Immunomodulatory role of C10 chemokine in a murine model of allergic
bronchopulmonary aspergillosis. J Immunol 1999;162(10):6071-6079.
HOGABOAM CM,BLEASE K, MEHRAD B,STEINHAUSER ML,STANDIFORD TJ,KUNKEL SL, et al. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol 2000;156(2):723-732.
HOHLFELD J,FABEL H,HAMM H.The role of pulmonary surfactant in obstructive airways disease. Eur Respir J 1997 Feb;10(2):482-491.
HOHLFELD J, HOYMANN HG, MOLTHAN J,FABEL H, HEINRICH U. Aerosolized surfactant inhibits acetylcholine-induced airway obstruction in rats. Eur Respir J 1997 Oct;10(10):2198-2203.
HOHLFELD JM,AHLF K, ENHORNING G, BALKE K, ERPENBECK VJ,PETSCHALLIES J,et al.
Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge.
Am J Respir Crit Care Med 1999 Jun;159(6):1803-1809.
HOHLFELD JM. Die Bedeutung des pulmonalen Surfactant-Systems beim Asthma bronchiale und nach Lungentransplantation: Untersuchung zur Funktion, Zusammensetzung und therapeutischen Einsetzbarkeit von Surfactant [Habilitationsschrift]. Hannover: Medizinische Hochschule Hannover; 1999
HOHLFELD JM.The role of surfactant in asthma. Am J Respir Crit Care Med 2002;3(1):4.
Epub 2001 Oct 15.
HOHLFELD JM,ERPENBECK VJ,KRUG N. Surfactant proteins SP-A and SP-D as modulators of the allergic inflammation in asthma. Pathobiology 2002-2003 Jun;70(5):287-292.
HOLGATE ST,PETERS-GOLDEN M,PANETTIERI RA,HENDERSON WRJR.Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003;111(1 Suppl):S18-34; discussion S34-S36.
HOLMSKOV U,LAWSON P,TEISNER B,TORNOE I,WILLIS AC,MORGAN Cet al.Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-glycoprotein-340), as a lung surfactant protein-D binding molecule. J Biol Chem 1997;272(21):13743-13749.
HOLT PG, BATTY JE, TURNER KJ. Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology 1981;42(3):409-417.
HOLT PG,SLY PD.Interactions between RSV infection, asthma, and atopy: unraveling the complexities. J Exp Med 2002;196(10):1271-1275.
HOPFENSPIRGER MT, AGRAWAL DK. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J Immunol 2002;168(5):2516-2522.
HOYMANN HG,HEINRICH U.Measurement of lung function in rodents in vivo. In: Uhlig S, Taylor AE, editors. Methods in Pulmonary Research. Basel: Birkhäuser Verlag; 1998.
p. 1-28
HOYMANN HG,HECHT M,EMMENDÖRFFER A,HOHLFELD J,HEINRICH U.Evaluation of the respiratory allergenicity of a fire-extinguisher powder in a rat model of allergic asthma.
In: Heinrich U, Mohr U, editors-in-chief. Relationships between acute and chronic effects of air pollution. Washington: ILSI Press; 2000. p. 385-392.
HOYMANN HG, KRUG N. Testverfahren für inhalative Testung auf allergenes Potenzial.
Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 2001;44:682-689.
HUMBLES AA,LU B,NILSSON CA,LILLY C,ISRAEL E,FUJIWARA Y,et al.A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 2000;406(6799):998-1001.
IRVIN CG, BATES JH. Measuring the lung function in the mouse: the challenge of size.
Respir Res 2003;4(1):4.
JAGANNATH C, HOFFMANN H, SEPULVEDA E, ACTOR JK, WETSEL RA, HUNTER RL.
Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5). Scand J Immunol 2000;52(4):369-379.
JARJOUR NN, ENHORNING G. Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant. Am J Respir Crit Care Med 1999;160(1):336-341.
JOHN M. Antiinflammatorische Zytokine in der Pathogenese des Asthma bronchiale:
Untersuchungen an pulmonalen Entzündungszellen und humanen Bronchialmyozyten [Habilitationsschrift]. Berlin: Humboldt-Universität Berlin; 2002
KAKUTA Y,SASAKI H,TAKISHIMA T.Effect of artificial surfactant on ciliary beat frequency in guinea pig trachea. Respir Physiol 1991;83(3):313-321.
KAROL MH.Animal models of occupational asthma. Eur Respir J 1994;7(3):555-568.
KASPER M, SIMS G, KOSLOWSKI R, KUSS H, THUEMMLER M, FEHRENBACH H, et al.
Increased surfactant protein D in rat airway goblet and Clara cells during ovalbumin-induced allergic airway inflammation. Clin Exp Allergy 2002;32(8):1251-1258.
KASSERRA CE, HARRIS P, STENTON GR, ABRAHAM W, LANGLANDS JM. IPL576,092, a
novel anti-inflammatory compound, inhibits leukocyte infiltration and changes in lung function in response to allergen challenge. Pulm Pharmacol Ther 2004;17(5):309-318.
KISHOR U, MADAN T, SARMA PU, SINGH M, URBAN BC, REID KB. Protective roles of pulmonary surfactant proteins , SP-A and SP-D, against lung allergy and infection caused by Aspergillus fumigatus. Immunobiology 2002;205(4-5):610-618.
KONIETZKO N, FABEL H, Herausgeber. Weißbuch Lunge 2000. Die Lunge und ihre Erkrankungen: Zur Lage und Zukunft der Pneumologie in Deutschland. Stuttgart:
Georg Thieme Verlag; 2000
KORSGREN M,ERJEFALT JS,KORSGREN O,SUNDLER F,PERSSON CG.Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 1997;185(5):885-892.
KRANEVELD AD, VAN DER KLEIJ HP,KOOL M, VAN HOUWELINGEN AH,WEITENBERG AC, REDEGELD FA, et al. Key role for mast cells in nonatopic asthma. J Immunol 2002;169(4):2044-2053.
KREMLEV SG,UMSTEAD TM, PHELPS DS. Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am J Physiol 1994;267(4 Pt 1):L357-L364.
KROEGEL C, BARNES NC. Asthma bronchiale: pathogenetische Grundlagen, Diagnostik, Therapie. 2. Auflage. Stuttgart: Thieme; 2002
KURASHIMA K,FUJIMURA M,TSUJIURA M,MATSUDA T.Effect of surfactant inhalation on allergic bronchoconstriction in guinea pigs. Clin Exp Allergy 1997 Mar;27(3):337-342.
KURASHIMA K,FUJIMURA M,MATSUDA T,KOBAYASHI T.Surface activity of sputum from acute asthmatic patients. Am J Respir Crit Care Med 1997 Apr;155(4):1254-1259 KURUP VP, GUO J, MURALI PS, CHOI HY, FINK JN. Immunopathologic responses to
Aspergillus antigen in interleukin-4 knockout mice. J Lab Clin Med 1997 Dec;130(6):567-575.
KURUP VP, MURALI PS, GUO J, CHOI HY, BANERJEE B, FINK JN, COFFMAN RL. Anti-interleukin (IL)-4 and -IL-5 antibodies downregulate IgE and eosinophilia in mice exposed to Aspergillus antigens. Allergy 1997 Dec;52(12):1215-1221.
KURUP VP,CHOI HY,MURALI PS,XIA J-Q,COFFMAN RL,FINK JN.Immune responses to Aspergillus antigen in IL-4-/-mice and the effect of eosinophil ablation. Allergy 1999;54(5):420-427.
LACK G, BRADLEY KL, HAMELMANN E, RENZ H, LOADER J, LEUNG DYet al. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J
Immunol 1996;157(4):1432-1439.
LECKS HI, WOOD DW, KRAVIS LP, SUTICK AI. Pulmonary surfactants, segmental atelectasis, and bronchial asthma. Clin Pediatr 1967;6(5):270-276.
LEVINE AM,WHITSETT JA,GWOZDZ JA,RICHARDSON TR,FISHER JH,BURHANS MSet al.
Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000;165(7):3934-3940.
LEVTCHENKO E, RAMET J. Exogenous surfactant therapy for status asthmaticus. Eur J Pediatr 1997;156(6):508.
LIKENS SA,MAUDERLY JL.Effect of elastase or histamine on single-breath N2 washouts in the rat. Respirat Environ Exercise Physiol 1982;52(1):141-146.
LIN CC. Noninvasive method to mesure airway obstruction in nonanesthetized allergen-sensitized and challenged mice. Respiration 2001;68(2):178-185.
LIU M,WANG L,LI E,ENHORNING G.Pulmonary surfactant will secure free airflow through a narrow tube. J Appl Physiol 1991;71(2):742-748.
LIU M, WANG L, ENHORNING G. Surfactant dysfunction develops when the immunized guinea-pig is challenged with ovalbumin aerosol. Clin Exp Allergy 1995;25(11):1053-1060.
LIU M,WANG B,HOLM A,ENHORNING G.Dysfunction of guinea-pig pulmonary surfactant and type II pneumocytes after repetitive challenge with aerosolized ovalbumin. Clin Exp Allergy 1997;27(7):802-807.
LIU YH,KAO MC,LAI YL,TSAI JJ.Efficacy of local nasal immunotherapy for Dp2-induced airway inflammation in mice: Using Dp2 peptide and fungal immunomodulatory peptide. J Allergy Clin Immunol 2003;112(2):301-310.
LIZENKO MV, PETROVSKII VI, KOTENKO TV. Izmenenie lipidnogo sostava lipoproteidov syvorotki krovi v protsesse lecheniia gormonami bol'nykh bronkhial'noi astmoi. Ter Arkh 1995;67(11):35-38.
LLOYD CM, GONZALO JA, COYLE AJ, GUTIERREZ-RAMOS JC. Mouse models of allergic airway disease. Adv Immunol 2001;77:263-295.
LUNDBLAD LK, IRVIN CG, ADLER A, BATES JH. A reevaluation of the validity of unrestrained plethysmography in mice. J Appl Physiol 2002;93(4):1198-1207.
MADAN T,KISHORE U,SHAH A,EGGLETON P,STRONG P,WANG JY,et al.Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils. Clin
Exp Immunol 1997;110(2):241-249.
MADAN T, KISHORE U, SINGH M, STRONG P, CLARK H, HUSSAIN EM, et al. Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens. J Clin Invest 2001;107(4):467-475.
MARIASSY AT. Epithelial cells of trachea and bronchi. In: Parent RA, editor. Comparative Biology of the Normal Lung. Volume 1. Boca Raton, Florida: CRC Press; 1992. p. 63-83.
MARIENCHECK W, CROUCH E. Modulation of surfactant protein D expression by glucocorticoids in fetal rat lung. Am J Respir Cell Mol Biol 1994;10(4):419-429.
MARTIN TR, GERARD NP, GALLI SJ, DRAZEN JM. Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol 1988;64(6):2318-2323.
MCEACHREN TM, KEOUGH KM. Phosphocholine reverses inhibition of pulmonary surfactant adsorption caused by C-reactive protein. Am J Physiol 1995;269(4 Pt 1):L492-497.
MCMENAMIN C, HOLT PG. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J Exp Med 1993;178(3):889-899.
MEHLHOP PD, VAN DE RIJN M,GOLDBERG AB,BREWER JP,KURUP VP,MARTIN TR, et al.
Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci U S A 1997;94(4):1344-1349.
MEYER KC, ZIMMERMANN JJ. Inflammation and surfactant. Paediatr Respir Rev 2002;3(4):308-14.
MITZNER W, TANKERSLEY C. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography [correspondence]. Am J Respir Crit Care Med 1998;158(1):340-341.
MITZNER W,TANKERSLEY C.Interpreting Penh in mice [letter to the editor]. J Appl Physiol